0001209191-23-045263.txt : 20230810 0001209191-23-045263.hdr.sgml : 20230810 20230810084108 ACCESSION NUMBER: 0001209191-23-045263 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230808 FILED AS OF DATE: 20230810 DATE AS OF CHANGE: 20230810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamothe Jeffrey G. CENTRAL INDEX KEY: 0001679967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 231157367 MAIL ADDRESS: STREET 1: 2401 4TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-08 0 0001671584 Aptevo Therapeutics Inc. APVO 0001679967 Lamothe Jeffrey G. C/O APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 0 1 0 0 EVP, COO 0 Common Stock 2023-08-08 4 M 0 11979 A 24671 D Common Stock 2023-08-08 4 M 0 1833 A 26504 D Restricted Stock Unit 2023-08-08 4 M 0 11979 0.00 D Common Stock 11979 11979 D Restricted Stock Unit 2023-08-08 4 M 0 1833 0.00 D Common Stock 1833 3667 D Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023. On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023. /s/ SoYoung Kwon, Attorney-in-Fact 2023-08-10